Nadezhda A. Malkova

Novosibirsk, NVS, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Epidemiology of multiple sclerosis in the city of Novosibirsk

Epidemiology of multiple sclerosis in the city of Novosibirsk

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: February 11, 2025

Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS

Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: April 27, 2024

Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS

Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: August 10, 2023

POEMS-syndrome

POEMS-syndrome

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: August 10, 2023

Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2

Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: April 21, 2023

Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results

Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: February 27, 2023

Long-term treatment for multiple sclerosis with interferon beta-1b. Outcomes of an open, retrospective, observational study

Long-term treatment for multiple sclerosis with interferon beta-1b. Outcomes of an open, retrospective, observational study

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: August 01, 2022

Efficacy and safety of sampeginterferon β-1a in the treatment of relapsing remitting multiple sclerosis: results of 52 weeks of therapy in a randomized, double-blind clinical trial

Efficacy and safety of sampeginterferon β-1a in the treatment of relapsing remitting multiple sclerosis: results of 52 weeks of therapy in a randomized, double-blind clinical trial

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: February 17, 2022

Survey of diagnostic and treatment practices for multiple sclerosis in Russian Federation in comparison to European data.

Survey of diagnostic and treatment practices for multiple sclerosis in Russian Federation in comparison to European data.

Journal: Multiple sclerosis and related disorders

Published: June 26, 2021

The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis

The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: January 15, 2020

The new pegylated interferon beta-1a (sampeginterferon beta-1a, BCD-054) in the treatment of remitting multiple sclerosis

The new pegylated interferon beta-1a (sampeginterferon beta-1a, BCD-054) in the treatment of remitting multiple sclerosis

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: January 15, 2020

Susac syndrome, review and clinical case

Susac syndrome, review and clinical case

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: June 04, 2019

Showing 1-12 of 28

Last Updated: 09/26/2026